ArticleDrug design, development and therapy2025

Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts.

Xuehui Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.